|Bid||8.39 x 4000|
|Ask||8.57 x 4000|
|Day's Range||8.19 - 8.61|
|52 Week Range||7.70 - 33.97|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||21.31|
Subscribe to Yahoo Finance Plus to view Fair Value for AUPH
The Aurinia Pharmaceuticals Inc. ( NASDAQ:AUPH ) share price is down a rather concerning 32% in the last month. But...
Shares of commercial-stage autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) raced higher in early action Thursday morning, rising as much as 15.7%. Why did investors bid up Aurinia's shares?
Aurinia (AUPH) delivered earnings and revenue surprises of -13.64% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?